SCN5A and cardiac rhythm disease: A previously identified disease mutation in Nav1.5 associated with cardiac arrhythmia illustrates how the potential loss of palmitoylation at this crucial residue alters channel inactivation and dysregulates myocyte excitability to contribute to cardiac disease.